Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that shareholders Ms. Ma Li and Ms. Liu Shuqin plan to reduce their combined holdings of company shares by no more than 9.6333 million shares, representing no more than 2% of the company's current total share capital, through centralized bidding and block trading methods during the period from October 21, 2025 to January 20, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments